Back

RT-RPA-Cas12a-based discrimination of SARS-CoV-2 variants of concern

Zhao, W.; Tang, G.; Zhang, Z.; Tan, W.; Fei, L.; Sun, J.; Li, Y.; Zou, S.; Yang, Y.; Cai, K.; Li, S.; Wang, Z.; Liu, J.; Mao, G.; Ma, Y.; Zhao, G.-P.; Tian, Z.-G.

2022-05-16 infectious diseases
10.1101/2022.05.11.22274884 medRxiv
Show abstract

Timely and accurate detection of SARS-CoV-2 variants of concern (VOCs) is urgently needed for pandemic surveillance and control. However, current methods are limited by the low sensitivity, long turn-around time or high cost. Here, we report a nucleic acid testing-based method aiming to detect and discriminate SARS-CoV-2 VOCs by combining RT-RPA and CRISPR-Cas12a detecting assays (RRCd). With a detection limit of 10 copies RNA/reaction, RRCd was validated in 204 clinical samples, showing 99% positive predictive agreement and 100% negative predictive agreement, respectively. Critically, using specific crRNAs, representatives of single nucleotide polymorphisms and small deletions in SARS-CoV-2 VOCs including N501Y, T478K and {Delta}H69-V70 were discriminated by RRCd, demonstrating 100% accuracy in clinical samples with Ct < 33. The method completes within 65 min and could offer visible results without using any electrical devices, which may facilitate point-of-care testing of SARS-CoV-2 and its variants.

Matching journals

The top 2 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.